Banque Cantonale Vaudoise - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20
-25.9%
15,0000.0%0.00%0.0%
Q2 2023$27
-53.4%
15,0000.0%0.00%
-66.7%
Q1 2023$58
-65.9%
15,000
+175.2%
0.00%
-66.7%
Q4 2022$170
-99.9%
5,4500.0%0.01%
-43.8%
Q3 2022$274,000
+21.2%
5,4500.0%0.02%
+33.3%
Q2 2022$226,000
-38.6%
5,4500.0%0.01%
-25.0%
Q1 2022$368,000
+161.0%
5,450
+2377.3%
0.02%
+220.0%
Q4 2021$141,000
-66.3%
220
-99.6%
0.01%
-73.7%
Q3 2021$419,000
+35.2%
50,220
+151.1%
0.02%
+11.8%
Q4 2020$310,000
+6.2%
20,0000.0%0.02%
-10.5%
Q3 2020$292,00020,0000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders